Assignee
MYRIAD INT GMBH
DE·3 granted patents·4 pending applications·0 citations·filing 2016–2024
Top patents by PatentIndex Score
7 records- 0180US2024229150A1Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2024·Application pending·0 cites
- 0269US11913078B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2020·Granted Feb 27, 2024·0 cites·19 claims
- 0368US2022307090A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2022·Application pending·0 cites
- 0465US10851427B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2020·Granted Dec 1, 2020·0 cites·41 claims
- 0563US2019144949A1Method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancerMYRIAD INT GMBH·Filed 2019·Application pending·0 cites
- 0660US10577661B2Method for breast cancer recurrence prediction under endocrine treatmentMYRIAD INT GMBH·Filed 2016·Granted Mar 3, 2020·0 cites·19 claims
- 0742US2019010558A1Method for determining the risk of recurrence of an estrogen receptor-positive and her2-negative primary mammary carcinoma under an endocrine therapyMYRIAD INT GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MYRIAD INT GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →